
-
Philippines biodiversity hotspot pushes back on mining
-
Deal or no deal: What happens with Trump's July tariff deadline?
-
Canada turns to drones for reforestation after wildfires
-
US, Japan, India, Australia pledge mineral cooperation on China jitters
-
Son of kingpin 'El Chapo' to plead guilty to drug trafficking in US
-
Trump urges 60-day Gaza ceasefire deal ahead of Netanyahu visit
-
Partial verdict in Combs trial, jury will keep deliberating
-
Djokovic thanks 'miracle pills' after Wimbledon win
-
US college bans transgender athletes following swimming furor
-
Global stocks mixed as markets track US trade deal prospects
-
Djokovic up and running at Wimbledon in bid for Grand Slam history
-
Jury reaches partial verdict in Sean "Diddy" Combs trial
-
Giroud signs one-year deal with Ligue 1 club Lille
-
Gauff vows to make changes after shock Wimbledon exit
-
Gonzalo heads Real Madrid past Juventus and into Club World Cup quarters
-
Gauff crashes out of Wimbledon on day of shocks
-
Big automakers report US sales jump on pre-tariff consumer surge
-
'Alone' Zverev considers therapy after shock Wimbledon exit
-
Second seed Coco Gauff knocked out of Wimbledon
-
Switzerland comes to the aid of Red Cross museum
-
'That's life': No regrets for former champion Kvitova after Wimbledon farewell
-
AI videos push Combs trial misinformation, researchers say
-
UK govt guts key welfare reforms to win vote after internal rebellion
-
Polish supreme court ratifies nationalist's presidential vote win
-
Macron, Putin discuss Iran, Ukraine in first talks since 2022
-
French league launches own channel to broadcast Ligue 1
-
Man City left to reflect on Club World Cup exit as tournament opens up
-
Shock study: Mild electric stimulation boosts math ability
-
Europe swelters as surprise early summer heatwave spreads
-
Third seed Zverev stunned at Wimbledon
-
Israel expands Gaza campaign ahead of Netanyahu's US visit
-
Gaza mourns those killed in Israeli strike on seafront cafe
-
Rubio hails end of USAID as Bush, Obama deplore cost in lives
-
Berlusconi family sell Monza football club to US investment fund
-
UN aid meeting seeks end to Global South debt crisis
-
Trump ramps up Musk feud with deportation threat
-
French paparazzi boss handed 18-month suspended sentence for blackmail
-
Gilgeous-Alexander agrees record $285 mln extension: reports
-
Tearful former champion Kvitova loses on Wimbledon farewell
-
IMF urges Swiss to strengthen bank resilience
-
Sri Lanka eye top-three spot in ODI rankings
-
Trump hails new 'Alligator Alcatraz' migrant detention center
-
US Senate approves divisive Trump spending bill
-
Krejcikova toughs it out in Wimbledon opener, Sinner cruises
-
UK govt braces for crunch welfare reforms vote amid major rebellion
-
Shifting to Asia, Rubio meets Quad and talks minerals
-
Stocks diverge while tracking US trade deal prospects
-
Bruce Lee Club closes archive doors citing operating costs
-
Trump ramps up Musk feud with deportation, DOGE threats
-
BTS announces comeback for spring 2026

Researchers start to find clues on the trail of long Covid
Tens of millions of people across the world are thought to suffer from long Covid, but four years after the pandemic was declared this elusive condition still cannot be tested for -- let alone treated.
However research could be finally starting to find early clues on the trail of long Covid, raising hopes of future breakthroughs that may also illuminate other stubbornly ambiguous chronic syndromes.
Long Covid is the name given to a wide variety of symptoms still being suffered by people weeks and months after they first contracted the SARS-CoV-2 virus.
The most common are fatigue, shortness of breath, muscle pain and brain fog.
One notable study released last month showed there were significant differences in the proteins of the blood of more than 110 long Covid patients.
Onur Boyman, a Swiss researcher and senior author of the Science study, told AFP he believes this is a "central puzzle piece" in what keeps Covid raging for so long in the bodies of some people.
Part of the body's immune system called the complement system, which normally fights off infection by killing infected cells, remains active in people with long Covid, continuing to attack healthy targets and causing tissue damage, the researchers said.
Boyman said that when people recovered from long Covid, their complement system also improved, suggesting a strong link between the two.
"It shows that long Covid is a disease and you can actually measure it," Boyman said, adding the team hopes this could lead to a future test.
Researchers not involved in the study cautioned that this complement system "dysregulation" could not explain all the different ways that long Covid seems to attack patients.
Still, it is "great to see papers coming out now showing signals which might start to explain long Covid", said Claire Steves, professor of ageing and health at King's College London.
- 'Every aspect of my life' -
Lucia, a US-based long Covid sufferer who preferred not to give her last name, told AFP that "studies like these bring us a lot closer to understanding" the condition.
She pointed to another recent paper which found damage and fewer mitochondria in the muscles of long Covid patients, which could indicate why many patients become exhausted after even a small amount of exercise.
For Lucia, long Covid turned climbing up the stairs to her apartment into a daily battle.
When she first caught Covid in March 2020, Lucia said she could not have imagined how the condition would "affect every aspect of my life -- including socially and financially".
Lucia, a member of the Patient-Led Research Collaborative, emphasised that people with long Covid do not only have to deal with their many health issues.
They also have "to contend with disbelief or dismissal from the medical community or from within their social circles", she said.
The importance of supporting patients was highlighted by a BMJ study this week, which found that group rehab improved the quality of life of long Covid patients.
- Why has it been so hard? -
Ziyad Al-Aly, a clinical epidemiologist at Washington University in St Louis, said long Covid has been so elusive because it is a "multi-system disease".
"Our minds are trained to think about diseases based on organ systems" such as heart or lung disease, he told AFP.
But understanding the mechanisms behind long Covid could more broadly answer "why and how acute infections cause chronic disease", he said.
This means solving the mystery of long Covid may bolster the fight against other conditions such as chronic fatigue syndrome or lingering symptoms after influenza, increasingly referred to as "long flu".
While the true number of long Covid sufferers is difficult to determine, the World Health Organization says it could be between 10-20 percent of all people who have contracted the disease.
Research from the US Centers for Disease Control and Prevention has suggested that the percentage of people who get long Covid has decreased as new coronavirus variants have become less severe.
Vaccination against Covid has been shown to significantly reduce the chance that people will get long Covid, emphasising the importance of booster shots, researchers say.
P.M.Smith--AMWN